G6PC1 and cancer: For example, the tumor suppressor p53-mediated nuclear exclusion of FOXO1 is found to impair the activation of phosphoenolpyruvate carboxykinase 1 (PCK1) and glucose-6-phosphatase (G6Pase), thereby compromising gluconeogenesis and consequent glucose output in various cancer cell lines [86].